Header Logo

Connection

Robert Zurier to Humans

This is a "connection" page, showing publications Robert Zurier has written about Humans.
Connection Strength

0.260
  1. Zurier RB, Burstein SH. Cannabinoids, inflammation, and fibrosis. FASEB J. 2016 11; 30(11):3682-3689.
    View in: PubMed
    Score: 0.019
  2. Burstein SH, Zurier RB. Cannabinoids, endocannabinoids, and related analogs in inflammation. AAPS J. 2009 Mar; 11(1):109-19.
    View in: PubMed
    Score: 0.012
  3. Zurier RB, Sun YP, George KL, Stebulis JA, Rossetti RG, Skulas A, Judge E, Serhan CN. Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4. FASEB J. 2009 May; 23(5):1503-9.
    View in: PubMed
    Score: 0.011
  4. Stebulis JA, Johnson DR, Rossetti RG, Burstein SH, Zurier RB. Ajulemic acid, a synthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells. Life Sci. 2008 Nov 07; 83(19-20):666-70.
    View in: PubMed
    Score: 0.011
  5. Parker J, Atez F, Rossetti RG, Skulas A, Patel R, Zurier RB. Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid. Rheumatol Int. 2008 May; 28(7):631-5.
    View in: PubMed
    Score: 0.011
  6. Johnson DR, Stebulis JA, Rossetti RG, Burstein SH, Zurier RB. Suppression of fibroblast metalloproteinases by ajulemic acid, a nonpsychoactive cannabinoid acid. J Cell Biochem. 2007 Jan 01; 100(1):184-90.
    View in: PubMed
    Score: 0.010
  7. Stebulis JA, Rossetti RG, Atez FJ, Zurier RB. Fibroblast-like synovial cells derived from synovial fluid. J Rheumatol. 2005 Feb; 32(2):301-6.
    View in: PubMed
    Score: 0.009
  8. Burstein S, Zurier RB. Pain reduction and lack of psychotropic effects with ajulemic acid: comment on the article by Sumariwalla et al. Arthritis Rheum. 2004 Dec; 50(12):4078-9; author reply 4079-80.
    View in: PubMed
    Score: 0.009
  9. Zurier RB. Prostaglandins: then and now and next. Semin Arthritis Rheum. 2003 Dec; 33(3):137-9.
    View in: PubMed
    Score: 0.008
  10. Bidinger B, Torres R, Rossetti RG, Brown L, Beltre R, Burstein S, Lian JB, Stein GS, Zurier RB. Ajulemic acid, a nonpsychoactive cannabinoid acid, induces apoptosis in human T lymphocytes. Clin Immunol. 2003 Aug; 108(2):95-102.
    View in: PubMed
    Score: 0.008
  11. Zurier RB. Prospects for cannabinoids as anti-inflammatory agents. J Cell Biochem. 2003 Feb 15; 88(3):462-6.
    View in: PubMed
    Score: 0.008
  12. Zurier RB, Rossetti RG, Burstein SH, Bidinger B. Suppression of human monocyte interleukin-1beta production by ajulemic acid, a nonpsychoactive cannabinoid. Biochem Pharmacol. 2003 Feb 15; 65(4):649-55.
    View in: PubMed
    Score: 0.008
  13. Walker NJ, Zurier RB. Liver abnormalities in rheumatic diseases. Clin Liver Dis. 2002 Nov; 6(4):933-46.
    View in: PubMed
    Score: 0.007
  14. Furse RK, Rossetti RG, Seiler CM, Zurier RB. Oral administration of gammalinolenic acid, an unsaturated fatty acid with anti-inflammatory properties, modulates interleukin-1beta production by human monocytes. J Clin Immunol. 2002 Mar; 22(2):83-91.
    View in: PubMed
    Score: 0.007
  15. Furse RK, Rossetti RG, Zurier RB. Gammalinolenic acid, an unsaturated fatty acid with anti-inflammatory properties, blocks amplification of IL-1 beta production by human monocytes. J Immunol. 2001 Jul 01; 167(1):490-6.
    View in: PubMed
    Score: 0.007
  16. Burstein SH, Rossetti RG, Yagen B, Zurier RB. Oxidative metabolism of anandamide. Prostaglandins Other Lipid Mediat. 2000 Apr; 61(1-2):29-41.
    View in: PubMed
    Score: 0.006
  17. DeLuca P, Rossetti RG, Alavian C, Karim P, Zurier RB. Effects of gammalinolenic acid on interleukin-1 beta and tumor necrosis factor-alpha secretion by stimulated human peripheral blood monocytes: studies in vitro and in vivo. J Investig Med. 1999 May; 47(5):246-50.
    View in: PubMed
    Score: 0.006
  18. Zurier RB, Rossetti RG, Seiler CM, Laposata M. Human peripheral blood T lymphocyte proliferation after activation of the T cell receptor: effects of unsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids. 1999 May-Jun; 60(5-6):371-5.
    View in: PubMed
    Score: 0.006
  19. Rothman D, Allen H, Herzog L, Pilapil A, Seiler CM, Zurier RB. Effects of unsaturated fatty acids on interleukin-1beta production by human monocytes. Cytokine. 1997 Dec; 9(12):1008-12.
    View in: PubMed
    Score: 0.005
  20. Rossetti RG, Seiler CM, DeLuca P, Laposata M, Zurier RB. Oral administration of unsaturated fatty acids: effects on human peripheral blood T lymphocyte proliferation. J Leukoc Biol. 1997 Oct; 62(4):438-43.
    View in: PubMed
    Score: 0.005
  21. Soscia PN, Zurier RB. Antirheumatic drug therapy during pregnancy. Bull Rheum Dis. 1997 Apr; 46(2):2-4.
    View in: PubMed
    Score: 0.005
  22. Zurier RB, Rossetti RG, Jacobson EW, DeMarco DM, Liu NY, Temming JE, White BM, Laposata M. gamma-Linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial. Arthritis Rheum. 1996 Nov; 39(11):1808-17.
    View in: PubMed
    Score: 0.005
  23. Rothman D, DeLuca P, Zurier RB. Botanical lipids: effects on inflammation, immune responses, and rheumatoid arthritis. Semin Arthritis Rheum. 1995 Oct; 25(2):87-96.
    View in: PubMed
    Score: 0.005
  24. Rossetti RG, Seiler CM, Laposata M, Zurier RB. Differential regulation of human T lymphocyte protein kinase C activity by unsaturated fatty acids. Clin Immunol Immunopathol. 1995 Sep; 76(3 Pt 1):220-4.
    View in: PubMed
    Score: 0.005
  25. DeLuca P, Rothman D, Zurier RB. Marine and botanical lipids as immunomodulatory and therapeutic agents in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am. 1995 Aug; 21(3):759-77.
    View in: PubMed
    Score: 0.005
  26. DeMarco DM, Santoli D, Zurier RB. Effects of fatty acids on proliferation and activation of human synovial compartment lymphocytes. J Leukoc Biol. 1994 Nov; 56(5):612-5.
    View in: PubMed
    Score: 0.004
  27. Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with blackcurrant seed oil. Br J Rheumatol. 1994 Sep; 33(9):847-52.
    View in: PubMed
    Score: 0.004
  28. Tepper MA, Zurier RB, Burstein SH. Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity. Bioorg Med Chem. 2014 Jul 01; 22(13):3245-51.
    View in: PubMed
    Score: 0.004
  29. Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann Intern Med. 1993 Nov 01; 119(9):867-73.
    View in: PubMed
    Score: 0.004
  30. Zurier RB. Fatty acids, inflammation and immune responses. Prostaglandins Leukot Essent Fatty Acids. 1993 Jan; 48(1):57-62.
    View in: PubMed
    Score: 0.004
  31. Callegari PE, Zurier RB. Botanical lipids: potential role in modulation of immunologic responses and inflammatory reactions. Rheum Dis Clin North Am. 1991 May; 17(2):415-25.
    View in: PubMed
    Score: 0.003
  32. DeMarco D, Kunkel SL, Strieter RM, Basha M, Zurier RB. Interleukin-1 induced gene expression of neutrophil activating protein (interleukin-8) and monocyte chemotactic peptide in human synovial cells. Biochem Biophys Res Commun. 1991 Jan 31; 174(2):411-6.
    View in: PubMed
    Score: 0.003
  33. Pullman-Mooar S, Laposata M, Lem D, Holman RT, Leventhal LJ, DeMarco D, Zurier RB. Alteration of the cellular fatty acid profile and the production of eicosanoids in human monocytes by gamma-linolenic acid. Arthritis Rheum. 1990 Oct; 33(10):1526-33.
    View in: PubMed
    Score: 0.003
  34. Santoli D, Phillips PD, Colt TL, Zurier RB. Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids. J Clin Invest. 1990 Feb; 85(2):424-32.
    View in: PubMed
    Score: 0.003
  35. Baker DG, Krakauer KA, Tate G, Laposata M, Zurier RB. Suppression of human synovial cell proliferation by dihomo-gamma-linolenic acid. Arthritis Rheum. 1989 Oct; 32(10):1273-81.
    View in: PubMed
    Score: 0.003
  36. Han GM, O'Neil-Andersen NJ, Zurier RB, Lawrence DA. CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. Cell Immunol. 2008 May-Jun; 253(1-2):92-101.
    View in: PubMed
    Score: 0.003
  37. Bomalaski JS, Alvarez J, Touchstone J, Zurier RB. Alteration of uptake and distribution of eicosanoid precursor fatty acids by aspirin. Biochem Pharmacol. 1987 Oct 01; 36(19):3249-53.
    View in: PubMed
    Score: 0.003
  38. Ambrosio ALB, Dias SMG, Polikarpov I, Zurier RB, Burstein SH, Garratt RC. Ajulemic acid, a synthetic nonpsychoactive cannabinoid acid, bound to the ligand binding domain of the human peroxisome proliferator-activated receptor gamma. J Biol Chem. 2007 Jun 22; 282(25):18625-18633.
    View in: PubMed
    Score: 0.003
  39. Pedersen-Lane JH, Zurier RB, Lawrence DA. Analysis of the thiol status of peripheral blood leukocytes in rheumatoid arthritis patients. J Leukoc Biol. 2007 Apr; 81(4):934-41.
    View in: PubMed
    Score: 0.003
  40. Bomalaski JS, Clark MA, Zurier RB. Enhanced phospholipase activity in peripheral blood monocytes from patients with rheumatoid arthritis. Arthritis Rheum. 1986 Mar; 29(3):312-8.
    View in: PubMed
    Score: 0.002
  41. Bomalaski JS, Clark MA, Douglas SD, Zurier RB. Enhanced phospholipase A2 and C activities of peripheral blood polymorphonuclear leukocytes from patients with rheumatoid arthritis. J Leukoc Biol. 1985 Nov; 38(5):649-54.
    View in: PubMed
    Score: 0.002
  42. Bomalaski JS, Williamson PK, Zurier RB. Prostaglandins and the inflammatory response. Clin Lab Med. 1983 Dec; 3(4):695-717.
    View in: PubMed
    Score: 0.002
  43. Liu J, Li H, Burstein SH, Zurier RB, Chen JD. Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid. Mol Pharmacol. 2003 May; 63(5):983-92.
    View in: PubMed
    Score: 0.002
  44. Zurier RB. Prostaglandins, immune responses, and murine lupus. Arthritis Rheum. 1982 Jul; 25(7):804-9.
    View in: PubMed
    Score: 0.002
  45. Recht LD, Salmonsen R, Rosetti R, Jang T, Pipia G, Kubiatowski T, Karim P, Ross AH, Zurier R, Litofsky NS, Burstein S. Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid. Biochem Pharmacol. 2001 Sep 15; 62(6):755-63.
    View in: PubMed
    Score: 0.002
  46. Vassilopoulos D, Zurier RB, Rossetti RG, Tsokos GC. Gammalinolenic acid and dihomogammalinolenic acid suppress the CD3-mediated signal transduction pathway in human T cells. Clin Immunol Immunopathol. 1997 Jun; 83(3):237-44.
    View in: PubMed
    Score: 0.001
  47. Zurier RB, Doty J, Goldenberg A. Cyclic AMP response to prostaglandin E1 in mononuclear cells from peripheral blood and synovial fluid of patients with rheumatoid arthritis. Prostaglandins. 1977 Jan; 13(1):25-31.
    View in: PubMed
    Score: 0.001
  48. Karik? K, Rosenbaum H, Kuo A, Zurier RB, Barnathan ES. Stimulatory effect of unsaturated fatty acids on the level of plasminogen activator inhibitor-1 mRNA in cultured human endothelial cells. FEBS Lett. 1995 Mar 13; 361(1):118-22.
    View in: PubMed
    Score: 0.001
  49. Williams WV, Fang Q, Demarco D, VonFeldt J, Zurier RB, Weiner DB. Restricted heterogeneity of T cell receptor transcripts in rheumatoid synovium. J Clin Invest. 1992 Aug; 90(2):326-33.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.